Medicinal Inorganic Chemistry

https://doi.org/10.1016/S0898-8838(08)60271-8Get rights and content

Publisher Summary

Biomedical inorganic chemistry “Elemental Medicine” is an important new area of chemistry. Platinum complexes are now among the most widely used drugs for the treatment of cancer. Three injectable Pt(II) compounds have been approved and several other cis-diam(m)ine complexes are on clinical trials, including an oral Pt(IV) complex. Microbial resistance to established organic antibiotics is a potentially serious problem and provides an impetus for the development of novel antimicrobial metal compounds. With appropriate choice of ligands, it is possible to change the mode of Pt binding to DNA and to circumvent acquired resistance of cancer cells to cisplatin; a trinuclear Pt complex with two monofunctional Pt centers has recently been found to exhibit an intriguing new mode of DNA binding and has entered clinical trials. There is potential in the anti-HIV field. Polyoxometallates of the Keggin type bind to viral envelope sites on cell surfaces and interfere with virus adsorption.

References (638)

  • P.J. Sadler

    Advances Inorg. Chem.

    (1991)
  • D.B. Zamble et al.

    Trends Biochem. Sci.

    (1995)
  • M.M. McA'Nulty et al.

    J. Mutation Res. DNA Rep.

    (1996)
  • D. Yang et al.

    Prog. Biophys. Mol. Biol.

    (1996)
  • T.W. Hambley

    Coord. Chem. Rev.

    (1997)
  • T.G. Appleton

    Coord. Chem. Rev.

    (1997)
  • K. Nooter et al.

    Pathol. Res. Practice

    (1996)
  • K. Kawai et al.

    J. Biol. Chem.

    (1990)
  • S.J. Berners-Price et al.

    J. Inorg. Biochem.

    (1990)
  • T. Ishikawa et al.

    J. Biol. Chem.

    (1996)
  • T. Ishikawa et al.

    J. Biol. Chem.

    (1994)
  • D.C. Lemkuil et al.

    J. Biol. Chem.

    (1994)
  • B.L. Zhang et al.

    J. Inorg. Biochem.

    (1997)
  • B.L. Zhang et al.

    J. Inorg. Biochem.

    (1994)
  • G.K. Poon et al.

    J. Pharm. Biomed. Anal.

    (1995)
  • A. Aboussekhra et al.

    Cell

    (1995)
  • K. Tanaka et al.

    Trends Biol. Sci.

    (1994)
  • D. Locker et al.

    J. Mol. Biol.

    (1995)
  • A.I. Ivanov et al.

    J. Biol. Chem.

    (1998)
  • C.M. Riley et al.

    Anal. Chem.

    (1983)
  • P.J. Sadler
  • M.J. Abrams et al.

    Science

    (1993)
  • B. Rosenberg et al.

    Nature

    (1965)
  • B. Rosenberg et al.

    Nature

    (1969)
  • J.P. Whitehead et al.

    Met. Ions Biol. Sys.

    (1996)
  • J. Reedijk

    Chem. Commun.

    (1996)
  • M.J. Bloemink et al.

    Met. Ions Biol. Syst.

    (1996)
  • B. Lippert

    Met. Ions Biol. Sys.

    (1996)
  • M. Sabat et al.

    Met. Ions Biol. Sys.

    (1996)
  • J. Kozelka

    Met. Ions Biol. Sys.

    (1996)
  • P. Augé et al.

    Transition Met. Chem.

    (1997)
  • M. Boudvillan et al.

    Met. Ions Biol. Sys.

    (1996)
  • D.M.J. Lilley

    J. Biol. Inorg. Chem.

    (1996)
  • J. Zlatanova et al.

    FASEB J.

    (1998)
  • N. Farrell

    Met Ions Biol. Sys.

    (1996)
  • J. Arpalahti

    Met Ions Biol. Sys.

    (1996)
  • G. Los et al.
  • D. Gately et al.

    Br. J. Cancer

    (1993)
  • M.M. Gottesman

    Cancer Res.

    (1993)
  • P.A. Andrews et al.

    Cancer Res.

    (1988)
  • R.D. Christen et al.

    J. Clin. Invest.

    (1993)
  • S.Y. Sharp et al.

    Clin. Cancer Res.

    (1995)
  • S.L. Kelley et al.

    Science

    (1988)
  • S.J. Barton et al.

    Aust. J. Chem.

    (1999)
  • Y. Chen et al.

    Chem. Eur. J.

    (1998)
  • D. Yang et al.

    Biochemistry

    (1995)
  • Cited by (0)

    View full text